J Herbert Patterson - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

J Herbert Patterson

Showing results (41-50 of 69) with videos related to

Pageof 7

Sort By:

American Heart Journal|January 26, 2021

Variation in use and dosing escalation of renin angiotensin system, mineralocorticoid receptor antagonist, angiotensin receptor neprilysin inhibitor and beta-blocker therapies in heart failure and reduced ejection fraction: Association of comorbiditiesNancy M Albert, Rachel J Tyson, C Larry Hill, et al.

American Heart Journal|December 15, 2010

Prospective evaluation of the association between cardiac troponin T and markers of disturbed erythropoiesis in patients with heart failureKirkwood F Adams, Mandeep R Mehra, Ron M Oren, et al.

Journal of the American Heart Association|June 20, 2022

Angiotensin Receptor Neprilysin Inhibition and Associated Outcomes by Race and Ethnicity in Patients With Heart Failure With Reduced Ejection Fraction: Data From CHAMP-HFBrittany Chapman, Anne S Hellkamp, Laine E Thomas, et al.

Journal of Cardiac Failure|November 18, 2021

Comparative Effectiveness of Dosing of Medical Therapy for Heart Failure: From the CHAMP-HF RegistryStephen J Greene, Javed Butler, Anne S Hellkamp, et al.

JACC. Heart Failure|December 14, 2020

Heart Failure Hospitalization and Guideline-Directed Prescribing Patterns Among Heart Failure With Reduced Ejection Fraction PatientsPratyaksh K Srivastava, Adam D DeVore, Anne S Hellkamp, et al.

Journal of Cardiac Failure|May 14, 2013

Clinical pharmacy services in heart failure: an opinion paper from the Heart Failure Society of America and American College of Clinical Pharmacy Cardiology Practice and Research NetworkSherry K Milfred-Laforest, Sheryl L Chow, Robert J Didomenico, et al.

Pharmacotherapy|May 8, 2013

Journal of the American Heart Association|June 14, 2018

Characteristics and Treatments of Patients Enrolled in the CHAMP-HF Registry Compared With Patients Enrolled in the PARADIGM-HF TrialAdam D DeVore, Xiaojuan Mi, Laine Thomas, et al.

JAMA Cardiology|March 24, 2021

Comparison of New York Heart Association Class and Patient-Reported Outcomes for Heart Failure With Reduced Ejection FractionStephen J Greene, Javed Butler, John A Spertus, et al.

Pharmacogenetics and Genomics|May 3, 2005

Beta1-adrenergic receptor polymorphisms and left ventricular remodeling changes in response to beta-blocker therapySteven G Terra, Karen K Hamilton, Daniel F Pauly, et al.

Pageof 7

Search research articles

Showing results (41-50 of 69) with videos related to

Sort By:

Pageof 7

American Heart Journal|January 26, 2021

American Heart Journal|December 15, 2010

Prospective evaluation of the association between cardiac troponin T and markers of disturbed erythropoiesis in patients with heart failureKirkwood F Adams, Mandeep R Mehra, Ron M Oren, et al.

Journal of the American Heart Association|June 20, 2022

Journal of Cardiac Failure|November 18, 2021

Comparative Effectiveness of Dosing of Medical Therapy for Heart Failure: From the CHAMP-HF RegistryStephen J Greene, Javed Butler, Anne S Hellkamp, et al.

JACC. Heart Failure|December 14, 2020

Heart Failure Hospitalization and Guideline-Directed Prescribing Patterns Among Heart Failure With Reduced Ejection Fraction PatientsPratyaksh K Srivastava, Adam D DeVore, Anne S Hellkamp, et al.

Journal of Cardiac Failure|May 14, 2013

Pharmacotherapy|May 8, 2013

Journal of the American Heart Association|June 14, 2018

Characteristics and Treatments of Patients Enrolled in the CHAMP-HF Registry Compared With Patients Enrolled in the PARADIGM-HF TrialAdam D DeVore, Xiaojuan Mi, Laine Thomas, et al.

JAMA Cardiology|March 24, 2021

Comparison of New York Heart Association Class and Patient-Reported Outcomes for Heart Failure With Reduced Ejection FractionStephen J Greene, Javed Butler, John A Spertus, et al.

Pharmacogenetics and Genomics|May 3, 2005

Beta1-adrenergic receptor polymorphisms and left ventricular remodeling changes in response to beta-blocker therapySteven G Terra, Karen K Hamilton, Daniel F Pauly, et al.

Pageof 7